Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Pitoniak Timothy

2. Date of Event Requiring Statement (MM/DD/YYYY) 1/24/2022

3. Issuer Name and Ticker or Trading Symbol

ISSUER DIRECT CORP [ISDR]

(Last) (First) (Middle)

C/O ISSUER DIRECT CORP., ONE GLENWOOD DRIVE SUITE 1001

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Financial Officer /

(Street)

RALIEGH, NC 27603

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option to Purchase Common Stock	⁽¹⁾	⁽¹⁾	Common Stock	30000	$26.00	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Common Stock	20000	$0	D

Explanation of Responses:
(1)	This option to purchase common stock was granted on January 24, 2022 and vests as follows: over a four-year period at a rate of 7,500 shares of common stock underlying the option grant on the first, second, third and fourth anniversary of the date of grant. The closing price of the Issuer's common stock on January 24, 2022, the date of grant, was $26.00 per share. The Reporting Person must be an employee of the Issuer as of each vesting date. The option grant will expire on January 23, 2032. In the event of a Corporate Transaction (as defined in the Issuer's 2014 Equity Incentive Plan, as amended (the "Plan"), any unvested portion of the option grant will be immediately vested so long as the Reporting Person continues to be an employee of the Issuer at such time.
(2)	These restricted stock units were granted January 24, 2022 and vest on January 24, 2025. The closing price of the Issuer's common stock on January 24, 2022, the date of grant, was $26.00 per share. The Reporting Person must be an employee of the Issuer as of the vesting date. In the event of a Corporate Transaction (as defined in the Plan), any unvested portion of the restricted stock units shall be immediately vested so long as the Reporting Person continues to be an employee of the Issuer at such time.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Pitoniak Timothy C/O ISSUER DIRECT CORP. ONE GLENWOOD DRIVE SUITE 1001 RALIEGH, NC 27603			Chief Financial Officer